To compare transcutaneous bilirubin readings from the chest and forehead of inpatient and outpatient infants to investigate whether one site is more accurate for estimating serum bilirubin concentration.
INTRODUCTION
BiliChekt (SpectRx Corporation, Norcross, GA), a noninvasive skin reflectance meter, produces a reading in milligrams per deciliter that correlates well with serum bilirubin concentrations in newborn infants. [1] [2] [3] Ethnic background or skin color has not been found to interfere with the accuracy of BiliChekt readings. 1, 3, 4 Engle et al. 5 reported that BiliChekt readings obtained from the foreheads (according to the manufacturer's recommendation) of Hispanic infants in Texas significantly underestimated serum values. We postulated that the discrepancy they observed in BiliChekt estimates might be due to ambient light (especially sunlight) exposure, and that the skin of the anterior chest should be less affected by such an artefact since infants are generally clothed. Therefore, we hypothesized that BiliChekt readings from the chest would be more representative of the serum bilirubin concentration than those from the forehead (brow), especially after discharge from hospital. We tested this hypothesis by comparing BiliChekt readings obtained from the brow and anterior chest of in-patients and outpatients with simultaneously obtained serum bilirubin concentrations.
METHODS
The Human Research Review Committee of the University of New Mexico approved this study. Newborn infants born at the University of New Mexico Hospital, who were enrolled in a multicenter randomized controlled trial of tin-mesoporphyrin were eligible for enrollment if they were 12 to 36 hours of age, apparently healthy, and term. We excluded infants who were cared for in a special care nursery for more than 12 hours, those treated with nonroutine medications, as well as those with signs or symptoms of illness.
After written informed consent was obtained from parents, baseline demographic and historical data as well as data obtained from physical examination were recorded. Infants were then screened for hyperbilirubinemia between 12 and 36 hours of age or earlier if jaundiced. Rescreening for hyperbilirubinemia was conducted at least daily for up to 1 week. Screening could be conducted with BiliChekt alone when values were low. If the values exceeded a threshold of 12 mg/dl (205 mmol/l) or if the clinician preferred, screening was confirmed with a total serum bilirubin measurement in the clinical laboratory. Values were recorded for this ancillary study for infants whether they received study medication (tin-mesoporphyrin or sham injection) or not.
Total serum bilirubin was measured in our clinical laboratory using the Vitrost Chemistry Products Kit for newborn bilirubin. This method employs a slide separation technique to eliminate interfering substances and binding of bilirubin to a cationic mordant for direct spectrophotometric measurements at two wavelengths. The accuracy of this technique was verified monthly using unknown control samples at three concentrations obtained from Medical Analysis Systems, Camarillo, CA. The clinical laboratory value underestimated the controls by 0.4±0.4 mg/dl (7±7 mmol/l) (mean±SD). The coefficient of variation ranged from 3% at 17.8 mg/dl (304 mmol/l) to 8% at 1.3 mg/dl (22 mmol/ l). The majority of our specimens were closest to the middle control (6.4 mg/dl or 109 mmol/l) for which the mean difference was 0.1 mg/dl (2 mmol/l) and the coefficient of variation was 4%. The remaining two measures of bilirubin concentration consisted of transcutaneous BiliChekt measurements carried out according to the manufacturer's instructions on the forehead (brow) and on the midanterior chest wall at the level of the nipples. The instrument was calibrated before each estimate and five transcutaneous readings were integrated to produce each recorded estimate. All skin estimates were performed by research nurses with prior training with the instrument.
The linear regressions for the two skin sites were compared to each other using a modified two-stage t-statistic designed for this purpose. 6 The first stage tested whether the slopes of the two regression lines were statistically different. If they were not, then the second stage determined whether the elevations (distances between parallel lines) were statistically different. The values for degrees of freedom were assigned based on the number of infants involved rather than the number of tests, since multiple time points were obtained for each infant.
RESULTS
A total of 31 infants participated in this study, 24 while in-patients and 28 while outpatients; 17/31 were girls; 21 were Hispanic, six Native American, and four Caucasian. The median birth weight was 3155 g (range 2720 to 4720 g). A total of 102 sets of bilirubin measurements were obtained, 33 on the in-patient service and 69 during outpatient follow-up visits. The age range at sampling was 13.5 to 196 hours. Serum bilirubin ranged from 2.3 to 17.1 mg/dl (39 to 292 mmol/l).
For the 33 sets of in-patient measurements, the average serum bilirubin was 9.3±2.8 mg/dl (159±48 mmol/l) (mean±SD), the brow bilirubin 8.9±2.8 mg/dl (152±48 mmol/l), and the chest bilirubin 9.6±2.7 mg/dl (164±46 mmol/l). The Pearson correlation coefficients (r) were 0.89 and 0.93 for brow and chest measurements respectively. Linear regression plots for the two skin site measurements versus serum bilirubin concentrations for inpatients are represented in Figure 1a higher than brow measurements. The two regressions straddle and closely parallel the line of identity (slope ¼ 1.0). For the 69 sets of outpatient measurements, the average serum bilirubin was 10.6±3.7 mg/dl (181±63 mmol/l) (mean±SD), the brow bilirubin 8.5±3.0 mg/dl (145±51 mmol/l) and the chest bilirubin 10.0±3.2 mg/dl (171±55 mmol/L). The Pearson correlation coefficients (r) were 0.91 and 0.93 for brow and chest measurements respectively. Correlation coefficients and mean differences between serum and skin measures were similar for Hispanic, Caucasian, and Native American infants. Linear regression plots for the two skin site measurements versus serum bilirubin concentrations for outpatients are shown in Figure 1b . The slopes of the two lines are not significantly different (t ¼ 1.6, p ¼ 0.11) but the distance between the lines is highly significant (t ¼ À7.3, p<0.0001) with measurements from the chest consistently higher by an average of 1.5±1.3 mg/dl (26±22 mmol/ l). In both regressions, the slope is less than 1.0, lower for brow than for chest readings, so that transcutaneous readings tend to be farther below the serum bilirubin at higher concentrations. The difference between chest and brow measurements did not vary with time after discharge.
DISCUSSION
We found that BiliChekt readings closely reflect laboratory estimates of serum bilirubin while the infant is still in hospital whether they are obtained from the brow or the chest. Chest BiliChekt readings correlated with serum measurements marginally better than those from brow, and chest measurements averaged 0.4 mg/dl (7 mmol/l) higher while brow measurements averaged 0.3 mg/dl (5 mmol/l) lower than serum estimates. However, after discharge from the nursery, transcutaneous bilirubin estimates from both sites correlated well with serum bilirubin but were consistently lower than serum bilirubin concentrations. Measurements from the chest were closer to serum values, averaging 0.6 mg/dl (10 mmol/l) lower, while those from the brow averaged 2.1 mg/dl (36 mmol/l) lower.
The correlation coefficients we calculated are similar to those reported by others. [1] [2] [3] [4] [5] When brow and chest measurements are compared, chest readings tend to be higher than brow and closer to serum bilirubin measurements. Yamauchi and Yamanouchi 7 found that exposing normal newborn infants to daylight through nursery windows significantly affects the readings of a Minoltat transcutaneous bilirubinometer on the forehead but not on the sternum. They also found that removing the infant from exposure to sunlight for a day improved the correlation.
CONCLUSIONS
We conclude that BiliChekt readings from the brow and mid-chest are similar and they both closely approximate measures of serum bilirubin from term infants regardless of ethnicity when there is limited exposure to sunlight. BiliChekt readings from chest are superior to those obtained from the brow once infants are discharged home however. After discharge, brow readings significantly underestimate serum bilirubin concentrations especially in the higher ranges. This study provides an alternative explanation for the discrepancies observed by Engle et al. 5 They surmised that racial differences could account for their less favorable results. We speculate that the main reason for the superiority of chest readings is the limited light exposure of the chest compared to the brow. Although the manufacturer's recommendation is to use the brow, using the chest will significantly improve the ability of the BiliChekt instrument to estimate serum bilirubin and should be the preferred site.
